Medtronic plc 2025-2026 Proxy Voting Records

Description as filed by funds: Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Randall J. Hogan, III

Medtronic plc’s own tally for this item (“Elect Director: Randall J. Hogan, III”): 974,218,474 for, 16,327,778 against, per its Form 8-K filed October 21, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholders elected, by separate resolutions, each of the twelve nominees to the Board of Directors to hold office until the 2026 Annual General Meeting of the Company and until his or her successor is elected, as follows:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 243 asset managers below reported 409,428,740 for, 438,144 against, 184,296 abstained.

Showing the 25 largest of 243 asset managers. See all 243 in the interactive database.

Description as filed by funds: Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Joon S. Lee, M.D.

Medtronic plc’s own tally for this item (“Elect Director: Joon S. Lee, M.D.”): 984,707,922 for, 5,824,405 against, per its Form 8-K filed October 21, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholders elected, by separate resolutions, each of the twelve nominees to the Board of Directors to hold office until the 2026 Annual General Meeting of the Company and until his or her successor is elected, as follows:”
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 243 asset managers below reported 409,613,102 for, 253,778 against, 184,298 abstained.

Showing the 25 largest of 243 asset managers. See all 243 in the interactive database.

Description as filed by funds: Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Elizabeth G. Nabel, M.D.

Medtronic plc’s own tally for this item (“Elect Director: Elizabeth G. Nabel, M.D.”): 941,510,879 for, 49,104,608 against, per its Form 8-K filed October 21, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholders elected, by separate resolutions, each of the twelve nominees to the Board of Directors to hold office until the 2026 Annual General Meeting of the Company and until his or her successor is elected, as follows:”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 243 asset managers below reported 409,076,036 for, 790,854 against, 184,289 abstained.

Showing the 25 largest of 243 asset managers. See all 243 in the interactive database.

Description as filed by funds: Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Craig Arnold

Medtronic plc’s own tally for this item (“Elect Director: Craig Arnold”): 860,168,749 for, 129,336,374 against, per its Form 8-K filed October 21, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholders elected, by separate resolutions, each of the twelve nominees to the Board of Directors to hold office until the 2026 Annual General Meeting of the Company and until his or her successor is elected, as follows:”
Support: 87% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 242 asset managers below reported 404,396,839 for, 5,389,535 against, 200,160 abstained.

Showing the 25 largest of 242 asset managers. See all 242 in the interactive database.

Description as filed by funds: Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Scott C. Donnelly

Medtronic plc’s own tally for this item (“Elect Director: Scott C. Donnelly”): 953,977,029 for, 36,527,587 against, per its Form 8-K filed October 21, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholders elected, by separate resolutions, each of the twelve nominees to the Board of Directors to hold office until the 2026 Annual General Meeting of the Company and until his or her successor is elected, as follows:”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 242 asset managers below reported 409,073,644 for, 728,589 against, 184,301 abstained.

Showing the 25 largest of 242 asset managers. See all 242 in the interactive database.

Description as filed by funds: Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Lidia L. Fonseca

Medtronic plc’s own tally for this item (“Elect Director: Lidia L. Fonseca”): 957,039,072 for, 32,793,740 against, per its Form 8-K filed October 21, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholders elected, by separate resolutions, each of the twelve nominees to the Board of Directors to hold office until the 2026 Annual General Meeting of the Company and until his or her successor is elected, as follows:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 242 asset managers below reported 409,120,944 for, 681,216 against, 184,374 abstained.

Showing the 25 largest of 242 asset managers. See all 242 in the interactive database.

Description as filed by funds: Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): John P. Groetelaars

Medtronic plc’s own tally for this item (“Elect Director: John P. Groetelaars”): 977,157,923 for, 13,337,052 against, per its Form 8-K filed October 21, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholders elected, by separate resolutions, each of the twelve nominees to the Board of Directors to hold office until the 2026 Annual General Meeting of the Company and until his or her successor is elected, as follows:”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 242 asset managers below reported 409,763,373 for, 38,857 against, 184,302 abstained.

Showing the 25 largest of 242 asset managers. See all 242 in the interactive database.

Description as filed by funds: Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): William R. Jellison

Medtronic plc’s own tally for this item (“Elect Director: William R. Jellison”): 984,922,865 for, 5,565,192 against, per its Form 8-K filed October 21, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholders elected, by separate resolutions, each of the twelve nominees to the Board of Directors to hold office until the 2026 Annual General Meeting of the Company and until his or her successor is elected, as follows:”
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 242 asset managers below reported 409,800,341 for, 1,890 against, 184,302 abstained.

Showing the 25 largest of 242 asset managers. See all 242 in the interactive database.

Description as filed by funds: Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Gregory P. Lewis

Medtronic plc’s own tally for this item (“Elect Director: Gregory P. Lewis”): 972,648,057 for, 17,845,085 against, per its Form 8-K filed October 21, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholders elected, by separate resolutions, each of the twelve nominees to the Board of Directors to hold office until the 2026 Annual General Meeting of the Company and until his or her successor is elected, as follows:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 242 asset managers below reported 409,371,229 for, 431,003 against, 184,302 abstained.

Showing the 25 largest of 242 asset managers. See all 242 in the interactive database.

Description as filed by funds: Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Kevin E. Lofton

Medtronic plc’s own tally for this item (“Elect Director: Kevin E. Lofton”): 979,276,656 for, 11,217,586 against, per its Form 8-K filed October 21, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholders elected, by separate resolutions, each of the twelve nominees to the Board of Directors to hold office until the 2026 Annual General Meeting of the Company and until his or her successor is elected, as follows:”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 242 asset managers below reported 409,429,291 for, 372,942 against, 184,301 abstained.

Showing the 25 largest of 242 asset managers. See all 242 in the interactive database.

Description as filed by funds: Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Geoffrey S. Martha

Medtronic plc’s own tally for this item (“Elect Director: Geoffrey S. Martha”): 928,147,564 for, 62,347,780 against, per its Form 8-K filed October 21, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholders elected, by separate resolutions, each of the twelve nominees to the Board of Directors to hold office until the 2026 Annual General Meeting of the Company and until his or her successor is elected, as follows:”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 242 asset managers below reported 409,021,401 for, 751,506 against, 184,302 abstained.

Showing the 25 largest of 242 asset managers. See all 242 in the interactive database.

Description as filed by funds: Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Kendall J. Powell

Medtronic plc’s own tally for this item (“Elect Director: Kendall J. Powell”): 890,393,677 for, 98,996,461 against, per its Form 8-K filed October 21, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholders elected, by separate resolutions, each of the twelve nominees to the Board of Directors to hold office until the 2026 Annual General Meeting of the Company and until his or her successor is elected, as follows:”
Support: 90% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 242 asset managers below reported 396,282,756 for, 13,581,128 against, 200,173 abstained.

Showing the 25 largest of 242 asset managers. See all 242 in the interactive database.

Description as filed by funds: Approving an amendment to Article 177 of the Company's Articles of Association, to facilitate the capitalization of certain of the Company's non-distributable reserves;

Medtronic plc’s own tally for this item (“7. An amendment to Article 177 of the Company's Articles of Association, to facilitate the capitalization of certain of the Company's non-distributable reserves”): 988,783,308 for, 1,421,542 against — passed, per its Form 8-K filed October 21, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The shareholders approved an amendment to Article 177 of the Company's Articles of Association, to facilitate the capitalization of certain of the Company's non-distributable reserves.”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 244 asset managers below reported 409,979,682 for, 147 against, 178,240 abstained.

Showing the 25 largest of 244 asset managers. See all 244 in the interactive database.

Description as filed by funds: Approving amendments to the Company's Articles of Association, to update the advance notice provisions.

Medtronic plc’s own tally for this item (“9. Amendments to the Company's Articles of Association to update the advance notice provisions”): 984,572,748 for, 5,648,332 against — passed, per its Form 8-K filed October 21, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The shareholders approved amendments to the Company's Articles of Association to update the advance notice provisions.”
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of Medtronic plc’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Adopt Advance Notice Requirement” (3 managers, 13,338 for).

The 244 asset managers below reported 408,973,969 for, 1,005,861 against, 178,238 abstained.

Showing the 25 largest of 244 asset managers. See all 244 in the interactive database.

Description as filed by funds: Authorizing the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares;

Medtronic plc’s own tally for this item (“6. Authorization of the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares”): 1,079,159,483 for, 26,833,237 against — passed, per its Form 8-K filed October 21, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The shareholders approved authorization of the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 245 asset managers below reported 410,772,525 for, 2,809 against, 289 abstained.

Showing the 25 largest of 245 asset managers. See all 245 in the interactive database.

Description as filed by funds: Renewing the Board of Directors' authority to issue shares under Irish law;

Medtronic plc’s own tally for this item (“4. Renewal of the Board's authority to issue shares under Irish law”): 1,088,658,571 for, 18,920,739 against — passed, per its Form 8-K filed October 21, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The shareholders approved renewal of the Board's authority to issue shares under Irish law.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 244 asset managers below reported 408,640,631 for, 1,517,338 against, 101 abstained.

Showing the 25 largest of 244 asset managers. See all 244 in the interactive database.

Description as filed by funds: Renewing the Board of Directors' authority to opt out of pre- emption rights under Irish law;

Medtronic plc’s own tally for this item (“5. Renewal of the Board's authority to opt out of pre-emption rights under Irish law”): 1,035,397,744 for, 71,865,014 against — passed, per its Form 8-K filed October 21, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The shareholders approved renewal of the Board's authority to opt out of pre-emption rights under Irish law.”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of Medtronic plc’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Eliminate Pre-Emptive Rights” (3 managers, 13,338 for).

The 244 asset managers below reported 408,443,774 for, 1,688,677 against, 119 abstained.

Showing the 25 largest of 244 asset managers. See all 244 in the interactive database.

Description as filed by funds: Approving a Capital Reduction to Create Distributable Reserves under Irish Law; and

Medtronic plc’s own tally for this item (“8. A Capital Reduction to Create Distributable Reserves under Irish Law”): 1,104,381,417 for, 2,641,267 against — passed, per its Form 8-K filed October 21, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The shareholders approved a Capital Reduction to Create Distributable Reserves under Irish Law.”
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 243 asset managers below reported 409,871,348 for, 138 against, 178,238 abstained.

Showing the 25 largest of 243 asset managers. See all 243 in the interactive database.

Description as filed by funds: Approving, on an advisory basis, the Company's executive compensation;

Medtronic plc’s own tally for this item (“3. In a non-binding advisory vote, the compensation awarded to the Company's named executive officers”): 925,151,188 for, 64,820,280 against — passed, per its Form 8-K filed October 21, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The shareholders approved, in a non-binding advisory vote, the compensation awarded to the Company's named executive officers.”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of Medtronic plc’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Section 14A executive compensation” (21 managers, 510,764 for, 800 against, 6,397 abstained).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 232 managers: 409,470,556 for, 523,152 against, 178,264 abstained, 1 not voted. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 1,196 managers: 561,554,617 for, 41,706,744 against, 99,344 abstained, 226,985 not voted. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: Ratifying, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for fiscal year 2026 and authorizing, in a binding vote, the Board of Directors, acting through the Audit Committee, to set the auditor's remuneration;

Medtronic plc’s own tally for this item (“2. In a non-binding vote, the appointment of PricewaterhouseCoopers LLP as Medtronic's independent auditor for fiscal year 2026 and to authorize, in a binding vote, the Board of Directors, acting through the Audit Commit”): 1,006,339,555 for, 101,786,497 against — passed, per its Form 8-K filed October 21, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The shareholders ratified, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as Medtronic's independent auditor for fiscal year 2026 and to authorize, in a binding vote, the Board of Directors, acting through the Audit Committee, to set the auditor's remuneration.”
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 248 asset managers below reported 403,181,515 for, 6,812,922 against, 178,173 abstained.

Showing the 25 largest of 248 asset managers. See all 248 in the interactive database.